What is BIOLASE?
BIOLASE, Inc. is a global leader in the development, manufacturing, and marketing of advanced laser systems tailored for dental practitioners and their patients. Headquartered in Foothill Ranch, California, the company provides minimally invasive solutions for a wide array of dental procedures, including cosmetic, restorative, and surgical applications. Their product portfolio features Waterlase all-tissue dental lasers, diode soft-tissue lasers, and specialized hygiene lasers, alongside consumable products and accessories. BIOLASE's commitment to innovation in dental technology positions it as a key player in the healthcare sector, aiming to enhance patient care and clinical efficiency through its cutting-edge laser platforms.
How much funding has BIOLASE raised?
BIOLASE has raised a total of $89.5M across 9 funding rounds:
Debt
$8M
Share Placement
$5M
Share Placement
$35M
Share Placement
$10M
Share Placement
$12M
Debt
$6M
Stock Offering
$8.5M
Debt
$3M
Debt
$2M
Debt (2012): $8M with participation from Comerica
Share Placement (2014): $5M led by Oracle Partners L.P
Share Placement (2014): $35M supported by Oracle Partners, L.P., Camber Capital Management, LLC, Jack W. Schuler Living Trust, Eagle Growth Partners I and II, Trellus Partners, and Birchview Capital L.P.
Share Placement (2016): $10M featuring Jack W. Schuler Living Trust and Oracle Partners L.P.
Share Placement (2017): $12M backed by Jack W. Schuler and Oracle Investment Management
Debt (2018): $6M with participation from Bridge Bank
Stock Issuance/Offering (2019): $8.5M, investors not publicly disclosed
Debt (2019): $3M supported by Pacific Mercantile Bank
Debt (2020): $2M featuring PPP
Key Investors in BIOLASE
Bridge Bank
Bridge Bank is a financial institution that has provided debt financing to BIOLASE, indicating a role in supporting the company's operational and growth initiatives through credit facilities.
Comerica
Comerica, a financial services company, has been involved in providing debt financing to BIOLASE, suggesting a supportive relationship in the company's capital structure.
Pacific Mercantile Bank
Pacific Mercantile Bank, a commercial bank, has extended debt financing to BIOLASE, highlighting its role in facilitating the company's access to credit for its business operations and expansion.
What's next for BIOLASE?
The recent major strategic investment in BIOLASE signals a pivotal moment for the company, likely enabling accelerated research and development, expansion into new markets, and enhancement of its sales and distribution networks. This capital infusion is expected to bolster BIOLASE's competitive edge in the rapidly evolving dental technology landscape. The company's focus on minimally invasive procedures aligns with global healthcare trends, suggesting a strong potential for future growth and market penetration. Strategic partnerships and further technological advancements are anticipated as BIOLASE leverages this significant backing to solidify its position as an industry frontrunner.
See full BIOLASE company page
